Opaleye Management as of June 30, 2018
Portfolio Holdings for Opaleye Management
Opaleye Management holds 36 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axogen (AXGN) | 18.7 | $72M | 1.4M | 50.25 | |
| Loxo Oncology | 7.9 | $30M | 175k | 173.48 | |
| Codexis (CDXS) | 6.5 | $25M | 1.8M | 14.40 | |
| Fibrogen | 5.8 | $23M | 360k | 62.60 | |
| Blueprint Medicines (BPMC) | 5.8 | $22M | 350k | 63.48 | |
| Polarityte | 4.9 | $19M | 800k | 23.54 | |
| Deciphera Pharmaceuticals | 4.3 | $17M | 420k | 39.35 | |
| Viking Therapeutics (VKTX) | 3.0 | $11M | 1.2M | 9.49 | |
| Strongbridge Bioph shs usd | 2.8 | $11M | 1.8M | 6.00 | |
| Agios Pharmaceuticals (AGIO) | 2.8 | $11M | 130k | 84.22 | |
| Fennec Pharmaceuticals (FENC) | 2.5 | $9.9M | 945k | 10.44 | |
| Cymabay Therapeutics | 2.4 | $9.4M | 698k | 13.42 | |
| Tg Therapeutics (TGTX) | 2.1 | $8.2M | 625k | 13.15 | |
| AMAG Pharmaceuticals | 2.1 | $8.2M | 420k | 19.50 | |
| Miragen Therapeutics | 2.0 | $7.7M | 1.2M | 6.41 | |
| Ocular Therapeutix (OCUL) | 1.9 | $7.5M | 1.1M | 6.75 | |
| Magenta Therapeutics | 1.9 | $7.4M | 550k | 13.50 | |
| Audentes Therapeutics | 1.9 | $7.3M | 190k | 38.21 | |
| Sangamo Biosciences (SGMO) | 1.9 | $7.2M | 505k | 14.20 | |
| Xoma Corp Del (XOMA) | 1.7 | $6.7M | 320k | 20.88 | |
| Xencor (XNCR) | 1.7 | $6.7M | 180k | 37.01 | |
| Corium Intl | 1.7 | $6.4M | 800k | 8.01 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.6 | $6.2M | 1.2M | 5.20 | |
| Ultragenyx Pharmaceutical (RARE) | 1.6 | $6.1M | 80k | 76.86 | |
| Ptc Therapeutics I (PTCT) | 1.6 | $6.1M | 180k | 33.73 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $5.8M | 265k | 22.00 | |
| Chimerix (CMRX) | 1.4 | $5.5M | 1.2M | 4.76 | |
| Amarin Corporation | 1.4 | $5.4M | 1.8M | 3.09 | |
| Biofrontera | 1.2 | $4.8M | 391k | 12.15 | |
| Foamix Pharmaceuticals | 1.0 | $3.8M | 250k | 15.31 | |
| Epizyme | 1.0 | $3.7M | 275k | 13.55 | |
| ArQule | 0.6 | $2.3M | 420k | 5.53 | |
| Protalix BioTherapeutics | 0.3 | $1.3M | 3.1M | 0.43 | |
| Cti Biopharma | 0.2 | $804k | 161k | 4.98 | |
| Azurrx Biopharma | 0.1 | $417k | 130k | 3.21 | |
| Biolinerx Ltd-spons | 0.1 | $223k | 250k | 0.89 |
